NCT06625242 - A Study of Filgotinib in Korean Participants With Rheumatoid Arthritis | Biotech Hunter

Enrollment

118

Participants

Timeline

Start Date

October 22, 2024

Primary Completion Date

February 26, 2026

Study Completion Date

March 19, 2026

Conditions

Rheumatoid Arthritis

Interventions

DRUG

Filgotinib Maleate

Administered as oral tablets.

Trial Locations (15)

Eisai site #11, Anyang-si

Eisai site #01, Busan

Eisai site #09, Daegu

Eisai site #12, Daegu

Eisai site #06, Daejeon

Eisai site #15, Guri-si

Eisai site #02, Gwangju

Eisai site #13, Incheon

Eisai site #03, Seoul

Eisai site #04, Seoul

Eisai site #05, Seoul

Eisai site #07, Seoul

Eisai site #08, Seoul

Eisai site #10, Seoul

Eisai site #14, Seoul

All Listed Sponsors

lead

Eisai Korea Inc.

INDUSTRY